NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT06399757 2026-01-07A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsApollo Therapeutics LtdPhase 1/2 Recruiting100 enrolled